Browse the corpus

REFERENCES Aronoff GR, Bennett WM, Berns JS, et al, Drug Prescribing in Renal Failure: Dosing Guidelines for Adults and Children , 5th ed. Philadelphia, PA: American College of Physicians; 2007, p 58, 151. Bass JW, Freitas BC, Freitas AD, et al, “Prospective Randomized Double Blind Placebo-Controlled Evaluation of Azithromycin for the Treatment of Cat-Scratch Disease,” Pediatr Infect Dis J , 1998, 17(6):447-52. [PubMed 9655532 ] Bradley JS, Byington CL, Shah SS, et al, “The Management of Community-Acquired Pneumonia in Infants and Children Older Than 3 Months of Age: Clinical Practice Guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America”, Clin Infect Dis , 2011, 53(7):e25-76. [PubMed 21880587 ] Centers for Disease Control and Prevention (CDC), “Guidelines for the Prevention and Treatment of Opportunistic Infections Among HIV-Exposed and HIV-Infected Children: Recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics,” MMWR Recomm Rep , 2009, 58(RR-11):1-166. Available at file://aidsinfo.nih.gov/contentfiles/Pediatric_OI.pdf [PubMed 19730409 ] Centers for Disease Control and Prevention (CDC), “Recommended Antimicrobial Agents for the Treatment and Postexposure Prophylaxis of Pertussis: 2005 CDC Guidelines,” MMWR Recomm Rep , 2005, 54(RR-14):1-16. [PubMed 16340941 ] Centers for Disease Control and Prevention (CDC), "Sexually Transmitted Diseases Treatment Guidelines, 2010," MMWR Recomm Rep , 2010, 59(RR-12):1-110. [PubMed 21160459 ] Centers for Disease Control and Prevention (CDC), “Update to CDC's Sexually Transmitted Diseases Treatment Guidelines, 2006: Fluoroquinolones No Longer Recommended for Treatment of Gonococcal Infections,” MMWR Recomm Rep , 2007, 56(14):332-6. [PubMed 17431378 ] Centers for Disease Control and Prevention (CDC), "Update to CDC's Sexually Transmitted Diseases Treatment Guidelines, 2010: Oral Cephalosporins No Longer a Recommended Treatment for Gonococcal Infections”, MMWR Morb Mortal Wkly Rep , 2012, 61(31):590-4. [PubMed 22874837 ]

Centers for Disease Control and Prevention (CDC), “Update to CDC's Sexually Transmitted Diseases Treatment Guidelines, 2006: Fluoroquinolones No Longer Recommended for Treatment of Gonococcal Infections,” MMWR Recomm Rep , 2007, 56(14):332-6. [PubMed 17431378 ] Centers for Disease Control and Prevention (CDC), "Update to CDC's Sexually Transmitted Diseases Treatment Guidelines, 2010: Oral Cephalosporins No Longer a Recommended Treatment for Gonococcal Infections”, MMWR Morb Mortal Wkly Rep , 2012, 61(31):590-4. [PubMed 22874837 ] Coates P, Daniel R, Houston AC, et al, “An Open Study to Compare the Pharmacokinetics, Safety, and Tolerability of a Multiple-Dose Regimen of Azithromycin in Young and Elderly Volunteers,” Eur J Clin Microbiol Infect Dis , 1991, 10(10):850-2. [PubMed 1662630 ] Foulds G, Shepard RM, and Johnson RB, “The Pharmacokinetics of Azithromycin in Human Serum and Tissues,” J Antimicrob Chemother , 1990, 25(Suppl A):73-82. [PubMed 2154441 ] Ghanem KG and Workowski KA, “Management of Adult Syphilis,” Clin Infect Dis , 2011, 53(Suppl 3):110-28. [PubMed 22080265 ] Guay DR, “Pharmacokinetics of the New Macrolides,” Infect Med , 1992, 9:9-13. Heintz BH, Matzke GR, Dager WE, “Antimicrobial Dosing Concepts and Recommendations for Critically Ill Adult Patients Receiving Continuous Renal Replacement Therapy or Intermittent Hemodialysis,” Pharmacotherapy , 2009, 29(5):562-77. [PubMed 19397464 ] Hoffler D, Koeppe P, and Paeske B, “Pharmacokinetics of Azithromycin in Normal and Impaired Renal Function,” Infection , 1995, 23(6):356-61. [PubMed 8655206 ] Kaplan JE, Benson C, Holmes KH, et al, “Guidelines for Prevention and Treatment of Opportunistic Infections in HIV-infected Adults and Adolescents: Recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America,” MMWR Recomm Rep , 2009, 58(4):1-207. Kim MH, Berkowitz C, and Trohman RG, "Polymorphic Ventricular Tachycardia With a Normal QT Interval Following Azithromycin," Pacing Clin Electrophysiol , 2005, 28(11):1221-2. [PubMed 16359290 ] Kogan R, Martínez MA, Rubilar L, et al, “Comparative Randomized Trial of Azithromycin versus Erythromycin and Amoxicillin for Treatment of Community-acquired Pneumonia in Children,” Pediatr Pulmonol , 2003, 35(2):91-8. [PubMed 12526069 ]

Kim MH, Berkowitz C, and Trohman RG, "Polymorphic Ventricular Tachycardia With a Normal QT Interval Following Azithromycin," Pacing Clin Electrophysiol , 2005, 28(11):1221-2. [PubMed 16359290 ] Kogan R, Martínez MA, Rubilar L, et al, “Comparative Randomized Trial of Azithromycin versus Erythromycin and Amoxicillin for Treatment of Community-acquired Pneumonia in Children,” Pediatr Pulmonol , 2003, 35(2):91-8. [PubMed 12526069 ] Lockwood AM, Cole S, and Rabinovich M, "Azithromycin-Induced Liver Injury," Am J Health Syst Pharm , 2010, 67(10):810-4. [PubMed 20479103 ] Manhart LE, Broad JM, and Golden MR, “ Mycoplasma genitalium: Should We Treat and How?” Clin Infect Dis , 2011, 53(Suppl 3):129-42. [PubMed 22080266 ] Nahata MC, Koranyi KI, Gadgil SD, et al, “Pharmacokinetics of Azithromycin After Oral Administration of Multiple Doses of Suspension,” Antimicrob Agents Chemother , 1993, 37(2):314-16. [PubMed 8383944 ] Ray WA, Murray KT, Hall K, et al, "Azithromycin and the Risk of Cardiovascular Death," N Engl J Med , 2012, 366(20):1881-90. [PubMed 22591294 ] Shulman ST, Bisno AL, Clegg HW, et al, “Clinical Practice Guideline for the Diagnosis and Management of Group A Streptococcal Pharyngitis: 2012 Update by the Infectious Diseases Society of America,” Clin Infect Dis , 2012, 55(10):e86-102. [PubMed 22965026 ] Starke JR and Correa AG, “Management of Mycobacterial Infection and Disease in Children,” Pediatr Infect Dis J , 1995, 14(6):455-69. [PubMed 7667049 ] Stevens DL, Bisno AL, Chambers HF, et al (Infectious Disease Society of America [IDSA]), “Practice Guidelines for the Diagnosis and Management of Skin and Soft-Tissue Infections,” Clin Infect Dis , 2005; 41(10):1373–406. [PubMed 16231249 ] Vannier E and Krause PJ, “Human Babesiosis,” N Engl J Med , 2012, 366(25):2397-2407. [PubMed 22716978 ] Wahlstrom E, Zamora JU, and Teichman S, “Improvement in Cyclosporin-Associated Gingival Hyperplasia With Azithromycin Therapy,” N Engl J Med , 1995, 332(11):753-4. [PubMed 7854392 ] Wilson R and Wells AU, “Azithromycin in Bronchiectasis: When Should it be Used?” Lancet , 2012, 380(9842):627-9. [PubMed 22901872 ]

Vannier E and Krause PJ, “Human Babesiosis,” N Engl J Med , 2012, 366(25):2397-2407. [PubMed 22716978 ] Wahlstrom E, Zamora JU, and Teichman S, “Improvement in Cyclosporin-Associated Gingival Hyperplasia With Azithromycin Therapy,” N Engl J Med , 1995, 332(11):753-4. [PubMed 7854392 ] Wilson R and Wells AU, “Azithromycin in Bronchiectasis: When Should it be Used?” Lancet , 2012, 380(9842):627-9. [PubMed 22901872 ] Wilson W, Taubert KA, Gewitz M, et al, “Prevention of Infective Endocarditis. Guidelines From the American Heart Association. A Guideline From the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group,” Circulation , 2007, 115. [PubMed 17446442 ] Wong C, Jayaram L, Karalus N, et al, “Azithromycin for Prevention of Exacerbations in Non-Cystic Fibrosis Bronchiectasis (EMBRACE): A Randomized, Double-Blind, Placebo-Controlled Trial,” Lancet , 2012, 380(9842):660-7. [PubMed 22901887 ] Wormser GP, Dattwyler RJ, Shapiro ED, et al, “The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America,” Clin Infect Dis , 2006, 43(9):1089-134. [PubMed 17029130 ] Topic 8868 Version 54.0 © 2013 UpToDate, Inc. All rights reserved. | Subscription and License Agreement | Release: 21.6- C21.56 Licensed to: AsanBook Dig. Med. Lib. | Support Tag: [0604-27.109.116.13-23EAA62341-S244013.14]